Comparison of aqueous and aerosol beclomethasone sprays in nasal polyps

Phase 3

Recruiting

• Conditions: Inflammatory nasal polyp.; Nasal polyp, unspecified; J33.9

• Registration Number: IRCT20171030037093N32
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients from the age of 18-55 years who suffer from inflammatory nasal polyps
Obtaining written consent to participate in the study

Exclusion Criteria

Previous sensitivity to beclomethasone
Pregnancy or breast-feeding
Severe kidney, heart, liver, neurologic, collagen-vascular, malignancy disease, untreated bacterial or fungal infection
History of trauma and facial fractures
Use of systemic or topical steroids 30 days before study, nasal decongestant, antihistamines, sodium cromolyn, anticholinergics for 7 previous days, use of cardiovascular drugs, neuroleptics, hormones or any drug that causes allergic rhinitis
Tobacco consumption

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The sino-nasal outcomes test-22 average score. Timepoint: Before intervention and 2 months after intervention. Method of measurement: The sino-nasal outcomes test-22 questionnaire.;Lund-Mackay average score. Timepoint: 2 months after intervention (one time). Method of measurement: Sinus CT scan.